Nasdaq: CURX

Curanex Pharmaceuticals Inc (CURX)

Curanex Pharmaceuticals Inc is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker CURX. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
CURX
Exchange
Nasdaq
SEC CIK
2025942
Official filings
SEC EDGAR

Research CURX

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Curanex Pharmaceuticals Inc's stock ticker?

Curanex Pharmaceuticals Inc trades under the ticker symbol CURX on Nasdaq. Its SEC Central Index Key (CIK) is 2025942.

Where can I read Curanex Pharmaceuticals Inc's SEC filings?

The CURX SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Curanex Pharmaceuticals Inc has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze CURX's financial statements?

The CURX Financials page shows Curanex Pharmaceuticals Inc's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does CURX compare with its peers and the market?

The CURX Peer Comparison page lines Curanex Pharmaceuticals Inc up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.